Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY:CVS)

97.13 -0.98 (-1.00%)
Streaming Delayed Price Updated: 1:02 PM EDT, May 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
69 70 Next >
News headline image
3 Spectacular Stocks You Can Buy Now and Hold Forever ↗
The ultimate long-term investing strategy is buying stocks and holding them forever. 
Via The Motley Fool
News headline image
Stock Market Today: Walgreens Stock Edges Lower as Buyout Nears ↗
Walgreens Boots Alliance shares slipped slightly on Tuesday as investors adjusted positions ahead of its planned private equity deal. 
Via The Motley Fool
Topics Stocks
News headline image
S&P 500 Losers: 22 Stocks With Negative Returns Over Past 10 Years, And This One's Getting The Boot ↗
The S&P 500 Index is up over 200% over the past decade, but 22 stocks have declined during that period, and one is set to be removed soon. 
Via Benzinga
Topics Stocks
CVS Health Reportedly Keeps Gilead’s New HIV Preventative Shot Off Its Plans, Faces $290M Medicare Fraud Ruling ↗
Via Stocktwits
Topics Fraud
News headline image
What Does the Market Think About CVS Health? ↗
 
Via Benzinga
News headline image
3 Inflated Stocks We’re Skeptical Of
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or... 
Via StockStory
Topics Cannabis
News headline image
2 Safe Dividend Stocks to Buy Now That Could Help You Protect and Grow Your Wealth ↗
These low-risk stocks can provide you with reliable and steadily growing passive income. 
Via The Motley Fool
News headline image
Gilead Sciences' 99.9% Effective HIV Treatment Notches Another Win ↗
The drug is soon to launch in Europe with a new name and a big potential market. 
Via Investor's Business Daily
News headline image
Small-Cap Stocks Spotlight: KULR, SNYR, RR, IQST Leading Innovation – More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence Regulatory Compliance
News headline image
Gildea's Kite Pharma Just Acquired Interius—$350 Million Move Shakes Up Cancer Therapy ↗
Kite Pharma is acquiring Interius BioTherapeutics for $350 million, adding in vivo CAR T technology that could simplify treatment and expand patient access. 
Via Benzinga
News headline image
Gilead Topples On A Surprise Setback For Its 99.9% Effective HIV Drug ↗
Insurance coverage is key for any new drug. But it's looking tenuous for Gilead Sciences' newest HIV prevention drug. 
Via Investor's Business Daily
News headline image
CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its Plans ↗
CVS rejected coverage of Gilead's new HIV prevention drug Yeztugo, citing regulatory and financial factors, while facing nearly $290 million in Medicare overcharge penalties. 
Via Benzinga
News headline image
Q2 Earnings Highlights: Humana (NYSE:HUM) Vs The Rest Of The Health Insurance Providers Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at health insurance providers stocks,... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
Winners And Losers Of Q2: Elevance Health (NYSE:ELV) Vs The Rest Of The Health Insurance Providers Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Elevance Health (NYSE:ELV) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
Berkshire's UnitedHealth Bet Highlights Long-Term Confidence Despite Depressed Earnings ↗
Michael Burry and Warren Buffett invested in UnitedHealth, signaling confidence in its sector and potential for earnings recovery by 2027. 
Via Benzinga
News headline image
Synergy Corp. (NASDAQ: SNYR) 1,600+ Nationwide Store Rollout – PPCB, SNGX, BTAI, HIT + Other Disruptive Stocks Moving Now!
Via AB Newswire
Topics Artificial Intelligence
News headline image
This CVS Health Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗
 
Via Benzinga
News headline image
Wondering what's happening in today's S&P500 pre-market session? ↗
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
Costco Refuses To Stock Abortion Pill Mifepristone, Pointing To 'Low Demand' As Activist Groups Step Up Pressure On Retail Giants ↗
Costco won't sell abortion pill mifepristone in U.S. stores due to low demand amid pressure from religious groups. 
Via Benzinga
Topics Religion
News headline image
Corporate Crossroads: Government Eyes Intel Stake as Buffett Bets on Healthcare Giant
In a striking display of market intervention and strategic investment, two major corporate developments are sending ripples through the financial world. The U.S. government is reportedly considering an... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Inflation's Conundrum: Surging Producer Prices Clash with Steady Consumer Costs, Fueling Rate Uncertainty
The financial markets are grappling with a perplexing economic puzzle as recent inflation data presents a contradictory picture. July 2025 saw the Producer Price Index (PPI) surge significantly,... 
Via MarketMinute
Topics Economy Energy Supply Chain
News headline image
Get insights into the top movers in the S&P500 index of Friday's pre-market session. ↗
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses. 
Via Chartmill
News headline image
Health Insurance Providers Stocks Q2 Recap: Benchmarking Cigna (NYSE:CI)
Looking back on health insurance providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Cigna (NYSE:CI) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
Q2 Earnings Highlights: AMN Healthcare Services (NYSE:AMN) Vs The Rest Of The Healthcare Providers & Services Stocks
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare providers & services industry, including AMN Healthcare Services... 
Via StockStory
News headline image
Synergy Corp (NASDAQ: SNYR) “FOCUSfactor” Q2 +125% YoY Growth, 10th Consecutive Profitable Quarter – More Stocks Inside
Via AB Newswire
News headline image
Assessing CVS Health: Insights From 6 Financial Analysts ↗
 
Via Benzinga
News headline image
Health Insurance Providers Stocks Q2 Teardown: Cencora (NYSE:COR) Vs The Rest
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Cencora (NYSE:COR) and the rest... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
Healthcare Providers & Services Stocks Q2 Highlights: Pediatrix Medical Group (NYSE:MD)
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Pediatrix Medical Group (NYSE:MD) and its peers. 
Via StockStory
News headline image
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
CVS Q2 Deep Dive: Pharmacy Strength and Aetna Recovery Drive Guidance Boost
Diversified healthcare company CVS Health (NYSE:CVS) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 8.4% year on year to $98.92 billion. Its non-GAAP profit of $1.81 per share was... 
Via StockStory
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
69 70 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.